A larger randomized controlled trial that compared metformin with insulin in the treatment of gestational diabetes (MiG trial) suggested that metformin, alone or with supplemental insulin, is an effective and safe treatment option in regards to glycemic control and feto-maternal outcomes [14]. This evidence concerns the gene INS and gestational diabetes.